Philadelphia Pharmaceuticals PLC financials at a glance
Year | Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2009 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
0.00M | 1.73M | 1.26M | 4.49M | 10.43M | 10.30M | 6.80M | 6.93M | 8.00M | 9.11M | 7.70M | 1.90M | 0.00M | 0.00M | 8.40M | 0.00M |
GM % | Gross Margin % |
|
0.00% | 24.53% | 9.15% | 43.07% | 52.52% | 55.71% | 60.56% | 50.59% | 49.47% | 52.29% | 45.46% | 38.84% | 0.00% | 0.00% | 47.64% | 0.00% |
OM | Operating Margin |
|
0.00% | -9.75% | -35.61% | 19.42% | 31.23% | 28.97% | 12.71% | 15.28% | 15.96% | 18.56% | 6.09% | 2.84% | 0.00% | 0.00% | 16.12% | 0.00% |
EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||||||||
Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 7.5m | 0m | 0m | 7.5m | 7.5m | 0m | 7.5m |
OCF | Operating Cash Flow |
|
0.00M | -0.50M | 0.24M | -0.05M | 0.81M | 1.29M | 0.53M | -0.59M | 1.67M | 0.41M | 1.70M | -0.09M | 0.00M | 0.00M | 1.10M | 0.00M |
FCF | Free Cash Flow |
|
0.00M | -0.55M | 0.07M | -0.17M | 0.22M | 0.44M | -0.22M | -0.65M | 1.31M | 0.14M | 1.56M | 0.00M | 0.00M | 0.00M | 1.03M | 0.00M |
FCFS | Free Cash Flow Per Share |
|
0.00 | -0.07 | 0.01 | -0.02 | 0.03 | 0.04 | -0.04 | -0.09 | 0.17 | 0.02 | 0.21 | -0.01 | 0.00 | 0.00 | 0.14 | 0.00 |